NDC Pharmacologic Class N0000175615 Fusion Protein Inhibitors [MoA]

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Product Type
60574-4113Synagis PalivizumabInjection, SolutionIntramuscularMedimmune, LlcHuman Prescription Drug
60574-4114Synagis PalivizumabInjection, SolutionIntramuscularMedimmune, LlcHuman Prescription Drug

There are 2 NDC products with the pharmacologic class Fusion Protein Inhibitors [MoA].